[Federal Register Volume 87, Number 182 (Wednesday, September 21, 2022)]
[Notices]
[Page 57680]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20428]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-20-2022]


Foreign-Trade Zone (FTZ) 46--Cincinnati, Ohio; Authorization of 
Production Activity; Patheon Pharmaceuticals, Inc. (Pharmaceutical 
Products); Cincinnati, Ohio

    On May 19, 2022, Patheon Pharmaceuticals, Inc. submitted a 
notification of proposed production activity to the FTZ Board for its 
facilities within Subzone 46K, in Cincinnati, Ohio.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (87 FR 31982, May 26, 2022). On 
September 16, 2022, the applicant was notified of the FTZ Board's 
decision that no further review of the activity is warranted at this 
time. The production activity described in the notification was 
authorized, subject to the FTZ Act and the FTZ Board's regulations, 
including section 400.14.

    Dated: September 16, 2022.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2022-20428 Filed 9-20-22; 8:45 am]
BILLING CODE 3510-DS-P